Drug Profile
Neboglamine
Alternative Names: CR-2249; Nebostinel; XY 2401Latest Information Update: 08 Jun 2015
Price :
$50
*
At a glance
- Originator Rottapharm
- Developer Rottapharm; Rottapharm Madaus; Xytis
- Class Neuroprotectants; Nootropics; Pentanoic acids; Small molecules
- Mechanism of Action Glycine gated NMDA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Cocaine-related disorders; Schizophrenia
- Discontinued Alzheimer's disease; Major depressive disorder
Most Recent Events
- 08 Jun 2015 Phase-II development for schizophrenia (negative, cognitive and mood symptoms) and drug abuse (cocaine abuse) is ongoing in Italy and USA, respectively
- 08 Nov 2014 Phase-II development is ongoing in the US and Italy
- 10 Oct 2014 Rottapharm Madaus has been acquired by Meda